{"company": {"org_id": "00067916", "org_name_cn": "厦门特宝生物工程股份有限公司", "org_short_name_cn": "特宝生物", "org_name_en": "Xiamen Amoytop Biotech Co.,Ltd.", "org_short_name_en": "AMOYTOP", "main_operation_business": "重组蛋白质及其长效修饰药物研发、生产和销售。", "operating_scope": "　　一般项目：诊所服务。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目：医疗服务；依托实体医院的互联网医院服务。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）。报告期内，公司（含下属公司）股权投资额比去年同期减少75%，主要原因是去年同期新设成立四家下属公司。", "district_encode": "350205", "org_cn_introduction": "厦门特宝生物工程股份有限公司的主营业务是重组蛋白质及其长效修饰药物研发、生产和销售。公司的主要产品是派格宾、益佩生、珮金、特尔立、特尔津、特尔康、愈适达。公司产品荣膺国家重大新药创制科技重大专项成果，成功入选“2023年度中国医药生物技术十大进展”，获评“2024年度药物创新成就奖”。", "legal_representative": "孙黎", "general_manager": "孙黎", "secretary": "杨毅玲", "established_date": 839347200000, "reg_asset": 406800000.0, "staff_num": 2423, "telephone": "86-592-6889118", "postcode": "361028", "fax": "86-592-6889130", "email": "ir@amoytop.com", "org_website": "www.amoytop.com", "reg_address_cn": "福建省厦门市海沧区新阳工业区翁角路330号", "reg_address_en": null, "office_address_cn": "福建省厦门市海沧区新阳工业区翁角路330号", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1579190400000, "provincial_name": "福建省", "actual_controller": "杨英 (33.94%)，孙黎 (8.37%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "孙黎", "executives_nums": 18, "actual_issue_vol": 46500000.0, "issue_price": 8.24, "actual_rc_net_amt": 330446320.0, "pe_after_issuing": 209.46, "online_success_rate_of_issue": 0.0466318, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}}